-
Je něco špatně v tomto záznamu ?
Therapeutic potential and limitations of curcumin as antimetastatic agent
P. Dytrych, Z. Kejík, J. Hajduch, R. Kaplánek, K. Veselá, K. Kučnirová, M. Skaličková, A. Venhauerová, D. Hoskovec, P. Martásek, M. Jakubek
Biomedicine & pharmacotherapy.
2023 ;
163 (-) :
114758.
[pub] 20230502
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články, přehledy
Perzistentní odkaz
https://www.medvik.cz/link/bmc23010904
- MeSH
- kurkumin * farmakologie terapeutické užití MeSH
- lidé MeSH
- nádory * farmakoterapie MeSH
- protinádorové látky * farmakologie terapeutické užití chemie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Treatment of metastatic cancer is one of the biggest challenges in anticancer therapy. Curcumin is interesting nature polyphenolic compound with unique biological and medicinal effects, including repression of metastases. High impact studies imply that curcumin can modulate the immune system, independently target various metastatic signalling pathways, and repress migration and invasiveness of cancer cells. This review discusses the potential of curcumin as an antimetastatic agent and describes potential mechanisms of its antimetastatic activity. In addition, possible strategies (curcumin formulation, optimization of the method of administration and modification of its structure motif) to overcome its limitation such as low solubility and bioactivity are also presented. These strategies are discussed in the context of clinical trials and relevant biological studies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010904
- 003
- CZ-PrNML
- 005
- 20230801132702.0
- 007
- ta
- 008
- 230718s2023 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2023.114758 $2 doi
- 035 __
- $a (PubMed)37141738
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Dytrych, Petr $u 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 2, 121 08 Prague, Czech Republic
- 245 10
- $a Therapeutic potential and limitations of curcumin as antimetastatic agent / $c P. Dytrych, Z. Kejík, J. Hajduch, R. Kaplánek, K. Veselá, K. Kučnirová, M. Skaličková, A. Venhauerová, D. Hoskovec, P. Martásek, M. Jakubek
- 520 9_
- $a Treatment of metastatic cancer is one of the biggest challenges in anticancer therapy. Curcumin is interesting nature polyphenolic compound with unique biological and medicinal effects, including repression of metastases. High impact studies imply that curcumin can modulate the immune system, independently target various metastatic signalling pathways, and repress migration and invasiveness of cancer cells. This review discusses the potential of curcumin as an antimetastatic agent and describes potential mechanisms of its antimetastatic activity. In addition, possible strategies (curcumin formulation, optimization of the method of administration and modification of its structure motif) to overcome its limitation such as low solubility and bioactivity are also presented. These strategies are discussed in the context of clinical trials and relevant biological studies.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kurkumin $x farmakologie $x terapeutické užití $7 D003474
- 650 12
- $a protinádorové látky $x farmakologie $x terapeutické užití $x chemie $7 D000970
- 650 12
- $a nádory $x farmakoterapie $7 D009369
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kejík, Zdeněk $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic
- 700 1_
- $a Hajduch, Jan $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic
- 700 1_
- $a Kaplánek, Robert $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic
- 700 1_
- $a Veselá, Kateřina $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic
- 700 1_
- $a Kučnirová, Kateřina $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic
- 700 1_
- $a Skaličková, Markéta $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic
- 700 1_
- $a Venhauerová, Anna $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic
- 700 1_
- $a Hoskovec, David $u 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 2, 121 08 Prague, Czech Republic
- 700 1_
- $a Martásek, Pavel $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic. Electronic address: pavel.martasek@lf1.cuni.cz
- 700 1_
- $a Jakubek, Milan $u BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455/2, 128 08 Prague, Czech Republic. Electronic address: milan.jakubek@lf1.cuni.cz
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 163, č. - (2023), s. 114758
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37141738 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132659 $b ABA008
- 999 __
- $a ok $b bmc $g 1963364 $s 1197169
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 163 $c - $d 114758 $e 20230502 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20230718
